Top Pharmaceutical Startups in Korea South (2025 Update)
Explore the best Pharmaceutical companies in Korea South. Discover high-growth startups and investment opportunities in our 2025 updated list.
👋🏼 Hello! I'm Bounce Watch, collecting insights from Top Pharmaceutical Startups in Korea South watchlist for you.
Real-Time Scouting Assistant

Explore Top Pharmaceutical Startups in Korea South featuring 82 Companies
|
![]() |
|||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
inCerebro | - | inCerebro is focused on developing a next-generation drug discovery technology t... | The company's proprietary MIND platform is specifically designed to identify nov... | - |
|
- | Korea South (HQ) + 1 | 2019 | Analytics, Biopharma +1 | [email protected] |
1
Low
|
12
|
322 (-63%) | 3 years ago | Seed | 3 | 5.0B | 30208 | 7 Tqi YFW | ||
|
FatiAbGen Inc. | - | Best in class multi-modality antibodies for difficult targets in high unmet need... | Fatiabgen is a leading antibody-based platform company with a broad clinical pip... | - |
|
- | Korea South (HQ) + 1 | 2020 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
7
|
559 | 1 year ago | Seed | 2 | 3.0M | 12574 | 1 year ago | ||
|
Standigm | - | The workflow AI drug discovery company | Standigm is a workflow AI-driven drug discovery company. Standigm has proprietar... | - |
|
- | Korea South (HQ) + 2 | 2015 | AI, Biotechnology +3 | [email protected] |
1
Low
|
30
|
818 | 3 years ago | Series D | 8 | 71.5M | 1506 | 9 months ago | ||
|
OliX Pharmaceuticals, Inc... | - | Contributing to the Health and Happiness of Mankind with RNAi Technology |
Accelerating Drug Development using Oligonucleotides Since its discovery, RNA i... |
- |
|
- | Korea South (HQ) | 2010 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
38
|
38.2K (-9%) | 4 years ago | Post Ipo Equity | 1 | 41.5B | 3682 | 7 months ago | ||
|
Panolos Bioscience | - | Frontrunner in structure-based protein design and development. Focused on multi-... | Panolos Bioscience is a frontrunner in structure-based protein design and develo... | - |
|
- | Korea South (HQ) | 2019 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
7
|
672 | 4 years ago | Series A | 1 | 20.0B | 194 | 1 year ago | ||
|
Primoris Co., Ltd. | - | Primoris develops 'Delivery Platform can load Effective Substance' and 'Function... | Primoris develops 'Delivery Platform can load Effective Substance' and 'Function... | - |
|
- | Korea South (HQ) | 2019 | Biotechnology, Pharmaceutical | - |
1
Low
|
2
|
566 | 4 years ago | Seed | 1 | 3.0B | 7491 | 6 Wh5 PSq | ||
|
Autotelic Bio Inc. | - | RNA Therapeutics New Drug Development Company | Autotelic Bio is a clinical-stage bioscience company pioneering next-generation... | - |
|
- | Korea South (HQ) + 1 | 2015 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
15
|
248 (-61%) | 3 years ago | Series B | 3 | 22.0B | 1442 | 5 months ago | ||
|
ONCOCROSS Co., Ltd. | - | AI, drug discovery development, biotechnology, indication expansion, rare diseas... | We are an AI biotech specializing in drug development based on transcriptomic da... | - |
|
- | Korea South (HQ) | 2015 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
14
|
2.7K (-18%) | 4 years ago | Corporate Round | 3 | 18.0B | 219 | 6 months ago | ||
|
CK Regeon | - | CK Regeon Inc. is a biotechnology-based company aiming to develop First-In-Class... | CK Regeon Inc. is a biotech-based company founded in October, 2016 aiming to dev... | - |
|
- | Korea South (HQ) | 2016 | Biotechnology, Health Care +1 | [email protected] |
1
Low
|
9
|
302 (-100%) | 4 years ago | Series B | 2 | 19.5B | 85 | 1 year ago | ||
|
NeuracleGenetics | - | AAV 벡터 기반 유전자치료제 연구개발 |
Gene Therapy Comes of Age Neuracle Genetics, established in May 2018 on the cam... |
- |
|
- | Korea South (HQ) | 2018 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
8
|
577 | 4 years ago | Series B | 1 | 30.0B | 130 | 8 months ago | ||
|
iN Therapeutics | - | 의학 및 약학 연구개발업 | iN Therapeutics is a spin-off biotech, from local leading pharmaceutical company... | - |
|
- | Korea South (HQ) | 2020 | Biotechnology, Health and Wellness +1 | - |
1
Low
|
8
|
1.2K (79%) | 3 years ago | Series B | 2 | 40.0B | 108 | 6 Hvc yPU | ||
|
Cyrus Therapeutics | - | Drugging the undruggable targets | Cyrus Therapeutics is a leading biotechnology company that is discovering and de... | - |
|
- | Korea South (HQ) | 2019 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
15
|
672 (-60%) | 3 years ago | Series B | 2 | 39.0B | 614 | 4 months ago | ||
|
RudaCure | - | For your quality and painless life | RudaCure is a biotechnology company founded in 2018 that is developing treatment... | - |
|
- | Korea South (HQ) + 1 | 2018 | Biotechnology, Pharmaceutical | - |
1
Low
|
13
|
940 (-15%) | 3 years ago | Series A | 2 | 21.0B | 158 | 2 years ago | ||
|
PharmCADD | - | PharmCADD is a company designed to accelerate drug discovery using technologies... | PharmCADD is a company designed to accelerate drug discovery meanwhile performin... | - |
|
- | Korea South (HQ) | 2019 | AI, Biotechnology +1 | - |
1
Low
|
19
|
479 | 4 years ago | Series B | 4 | 19.8M | 15131 | 9 TXH 7UL | ||
|
ImmuneOncia Therapeutics... | - | Changing the Standard of cancer treatment by bringing Korea's 1st immuno-oncolog... | ImmuneOncia is an immuno-oncology-centric biopharmaceutical company. Established... | - |
|
- | Korea South (HQ) + 1 | 2016 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
18
|
668 (231%) | 3 years ago | Series Unknown | 2 | 60.6M | 445 | 1 year ago | ||
|
CERES F&D | - | Solution for Biologics & Fermentations | Established in 2018, CERES F&D is a biopharmaceutical company that produces high... | - |
|
- | Korea South (HQ) + 1 | 2018 | Biotechnology, Manufacturing +1 | [email protected] |
1
Low
|
1
|
2.1K (5%) | 5 years ago | Series B | 2 | 9.5B | 43664 | 8 GX4 N4f | ||
|
Kanaph Therapeutics | - | We are the leader of next generation immuno-oncology and autoimmune diseases. | Kanaph Therapeutics is a drug discovery and pre-clinical stage biotech based in... | - |
|
- | Korea South (HQ) | 2019 | Biotechnology, Pharmaceutical | - |
1
Low
|
16
|
2.7K (-10%) | 4 years ago | Series B | 2 | 27.0M | 407 | 1 year ago | ||
|
Actnova | - | Powerful, Simple Behavior Analysis. |
액트노바는 '최고의 분석, 최소의 희생' 이라는 미션을 가집니다. 행동은 뇌의 활동... |
- |
|
- | Korea South (HQ) + 1 | 2019 | Manufacturing, Pharmaceutical | [email protected] |
1
Low
|
6
|
382 | 1 year ago | Seed | 2 | 3.8B | 28 | 1 year ago | ||
|
ABLE Labs (에이블랩스) | - | Empowering biologists to focus on discovery through lab automation expertise. | At ABLE Labs, our focus is on improving human health through the provision of la... | - |
|
- | Korea South (HQ) | 2021 | Biotechnology, Life Sciences +1 | [email protected] |
1
Low
|
24
|
1.4K (-13%) | 2 years ago | Seed | 2 | 4.0B | 887 | 11 months ago | ||
|
Mitoimmune Therapeutics I... | - | "Mighty Mitochondria For a Healthier Life!" | MitoImmune is a clinical stage biotech company that focuses on developing drugs... | - |
|
- | Korea South (HQ) | 2018 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
5
|
279 (534%) | 4 years ago | Series B | 2 | 39.5B | 97142 | 3 Ddj hm9 | ||
|
ExoCoBio | - | ExoCoBio improves the quality of life with exosome-based technology Our Exosomes... | The First and Leading Cosmeceutical/Biopharmaceutical Company based on Exosomes... | - |
|
- | Korea South (HQ) | 2017 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
28
|
116 (-100%) | 4 years ago | Series C | 3 | 47.0M | 14375 | 8 Aor TrE | ||
|
ZTI BIOSCIENCES | - | Radiopharmaceutical Platform: Fully-integrative Nano-Carrier Platform, compatibl... | ZTI BIOSCIENCES is a radiopharmaceutical developer for cancer therapy based on n... | - |
|
- | Korea South (HQ) + 2 | 2020 | Biotechnology, Pharmaceutical | - |
1
Low
|
20
|
1.3K (35%) | 3 years ago | Series A | 2 | 2.0B | 151 | 10 months ago | ||
|
Bionsight | - | Unlocking the transformative power of Chemoproteomics and AI in revolutionizing... | Bionsight is a drug discovery company that integrates the power of chemoproteomi... | - |
|
- | Korea South (HQ) | 2019 | AI, Pharmaceutical +1 | [email protected] |
1
Low
|
17
|
5.4K (-21%) | 1 year ago | Series A | 2 | 5.5M | 116 | 6 months ago | ||
|
Aston Sci. | - | Empowering Patients with Innovative Cancer Immunotherapy | Aston Sci. is a clinical-stage biopharmaceutical company that is currently focus... | - |
|
- | Korea South (HQ) + 2 | 2018 | Biotechnology, Pharmaceutical | - |
1
Low
|
8
|
23 | 4 years ago | Series C | 1 | 27.0B | 1005 | 1 year ago | ||
|
UPPTHERA, Inc. | - | Pharmaceutical company (New drug development) | UPPthera Inc is a pharmaceutical venture company aiming for new drug development... | - |
|
- | Korea South (HQ) | 2018 | Pharmaceutical | [email protected] |
1
Low
|
19
|
1.8K (141%) | 3 years ago | Series B | 2 | 28.0B | 281 | 5 months ago | ||
|
주식회사 마이허브앤헬스케... | - | 표준화된 데이터를 이용해 알기 쉽게 영양제를 성분과 함량별로 비교해 볼 수 있도록... | 영양제를 성분별로 알기 쉽게 비교해볼 수 있도록 '마이허브' 어플리케이션을 서비스... | - |
|
- | Korea South (HQ) | 2019 | Health Care, Mobile +2 | [email protected] |
1
Low
|
2
|
19365 | - | Seed | - | 40.0M | 47805 | 1 hl1 gVM | ||
|
EPD Biotherapeutics Inc. | - | Developing innovative therapies with Engineered Protein Degraders | Developing innovative therapies with Engineered Protein Degraders | - |
|
- | Korea South (HQ) | 2021 | Biotechnology, Pharmaceutical | - |
1
Low
|
2
|
255 (-35%) | 2 years ago | Series Unknown | 3 | 4.9B | 194 | 7 months ago | ||
|
에비드넷 EvidNet | - | #Big Data #RWD #RWE #AI #M/L #Federated Learning #Health Data analytics #Interop... | EvidNet is a heathcare IT company that provides Real World Evidence (RWE) soluti... | - |
|
- | Korea South (HQ) | 2017 | AI, Big Data +4 | [email protected] |
1
Low
|
31
|
44910 | - | Series B | - | 26.1M | 292 | 10 months ago | ||
|
PROTEINA | - | Our Protein-protein interaction (PPI) analysis platform enables quantitative mea... | PROTEINA has developed a first-in-class protein-protein interaction (PPI) analys... | - |
|
- | Korea South (HQ) | 2015 | Biotechnology, Health Care +2 | [email protected] |
1
Low
|
32
|
1.1K (-15%) | 3 years ago | Series C | 2 | 19.0B | 692 | 5 months ago | ||
|
CellBion | - | Advancing Global Healthcare with Innovative Radiopharmaceuticals | We are a dedicated and innovative radiopharmaceutical company committed to impro... | - |
|
- | Korea South (HQ) | 2010 | Biotechnology, Health and Wellness +1 | - |
1
Low
|
6
|
377 (-100%) | 1 year ago | Series Unknown | 3 | 8.0B | 65 | 1 year ago | ||
|
Wellmarker Bio (WMBIO) | - | Develops anticancer drugs based on predictive biomarkers with unmet needs | Wellmarker Bio is a spin-off company from Seoul Asan Medical Center(AMC), which... | - |
|
- | Korea South (HQ) | 2016 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
10
|
21 (-100%) | 3 years ago | Series C | 2 | 14.0B | 135 | 5 zcq kzt | ||
|
TSD Life Sciences | - | "암정복"을 위해 노력하는 바이오기업 | 티에스디라이프사이언스는 "암정복" 을 위해 최선의 노력을 다하는 바이오기업입니다.... | - |
|
- | Korea South (HQ) | 2016 | Biotechnology, Life Sciences +1 | [email protected] |
1
Low
|
10
|
791 (52%) | 3 years ago | Series A | 2 | 10.0B | 47 | 8 mjo Hip | ||
|
Onconic Therapeutics | - | - | Website | - |
|
- | Korea South (HQ) | 2020 | Health and Wellness, Pharmaceutical | - |
1
Low
|
10
|
1.2K (164%) | 2 years ago | Series B | 1 | 26.0B | 9505 | 6 PFQ Dgy | ||
|
MTHERA PHARMA | - | - | MThera Pharma Co., Ltd. is a biopharmaceutical company focused on developing nov... | - |
|
- | Korea South (HQ) | 2020 | Biotechnology, Pharmaceutical | - |
1
Low
|
8
|
206 | 2 years ago | Series Unknown | 6 | 3.5B | 91 | 5 months ago | ||
|
SCAI Therapeutics | - | - | SCAI Therapeutics | - |
|
- | Korea South (HQ) | 2019 | Biotechnology, Health and Wellness +1 | - |
1
Low
|
10
|
93 (-100%) | 3 years ago | Series B | 1 | 31.4B | 8151 | 7 VgJ EJ5 | ||
|
3billion | - | Your One Answer Genetic testing for rare diseases made more efficient and more... | 3billion is revolutionizing the existing methods and procedures to enable more p... | - |
|
- | Korea South (HQ) | 2016 | Health Care, Pharmaceutical +1 | [email protected] |
1
Low
|
58
|
75510 | - | Series C | - | 25.7M | 1999 | 5 months ago | ||
|
MEPSGEN | - | Micro Engineered Physiological Systems Guiding and Enabling the Next | MEPSGEN is a biotechnology company that develops human microphysiological system... | - |
|
- | Korea South (HQ) + 3 | 2019 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
22
|
12364 | - | Series A | - | 4.0B | 748 | 5 months ago | ||
|
basgenbio (바스젠바이오) | - | 유전체데이터를 기반으로 인류의 건강한 수명을 늘리는데 전력을 다하겠습니다. | 저희 (주)바스젠바이오는 국내 민간기업 최초 최대 규모인 한국인 15.6만명 기반의 바... | - |
|
- | Korea South (HQ) | 2018 | AI, Biotechnology +1 | [email protected] |
1
Low
|
19
|
35937 | - | Series A | - | 6.0B | 132 | 11 months ago | ||
|
Cellapeutics bio | - | Global standard of cell reprogramming platform | Cellapeutics Bio is a bio-venture company that develops cell therapy for the tre... | - |
|
- | Korea South (HQ) | 2020 | Biotechnology, Pharmaceutical | [email protected] |
1
Low
|
8
|
1.3K | 3 years ago | Seed | 3 | Unknown | 48 | 7 wae NEl | ||
|
NOBO Medicine | - | Precision Medicine in Oncology and Beyond | NOBO Medicine focuses on development of drugs driven by novel biomarkers. We ide... | - |
|
- | Korea South (HQ) | 2017 | Health Care, Pharmaceutical | [email protected] |
1
Low
|
7
|
740 | 7 years ago | Non Equity Assistance | 1 | Unknown | 47337 | 8 lem R2N |